By binding to GLP-1 receptors, semaglutide enhances insulin secretion in a glucose-dependent manner, meaning it stimulates insulin release only when blood glucose levels are elevated
B., Malecka-Panas, E., Ardizzone, S., D'Arienzo, A., Valpiani, D., Koch, M., Denapiene, G., Vago, G., Fociani, P., Zerbi, P., Ceracchi, M., Camerini, R., and Gasbarrini, G
They also understand which side effects are more manageable based on health history
That is the core problem with oral peptides, and it is why nearly every clinically proven peptide drug is injected
The active ingredient in Rybelsus 14mg is semaglutide 14mg